ORIC Pharmaceuticals Inc.

ORIC | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.67

-$0.12 (-0.94%)

At close: Sep 21, 2026, 4:00 PM ET

$12.76

+$0.09 (+0.71%)

Pre-market: Sep 22, 2026, 8:26 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.31B

Enterprise Value $1.05B

Beta 0.99

Average Volume 1.56M

Shares Outstanding (Diluted) 108.01M

Shares Change YoY 38.25%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US68622P1093

Price Performance

Price Change 1M -10.5%

Price Change 3M 42.2%

Price Change 6M 8.3%

Price Change YTD 55.1%

Price Change 1Y 17.1%

Price Change 3Y 62.2%

Price Change 5Y -46.6%

1M CAGR (ann.) -6.2%

1Y CAGR (ann.) 15.2%

5Y CAGR (ann.) -12.3%

All-Time CAGR -10.5%

Valuation

PE Ratio -9.39

Forward PE N/A

PEG Ratio -0.26

Forward PEG -0.88

PS Ratio N/A

Forward PS 593.00

PB Ratio 3.44

P/FCF Ratio -11.67

P/Adj. FCF Ratio -9.48

P/OCF Ratio -12.30

EV/Sales N/A

EV/EBIT -7.28

EV/EBITDA -7.33

EV/FCF -9.34

Earnings Yield -10.7%

FCF Yield -8.6%

Adj. FCF Yield -10.6%

Financial Health

Net Cash $261.44M

Total Debt $3.33M

Cash & Short-Term Investments $264.76M

Total Assets $404.69M

Current Ratio 13.19

Quick Ratio 13.19

Debt / Equity Ratio 0.01

Debt / EBITDA -0.02

Debt / FCF -0.03

OCF / Debt -33.58

Interest Coverage 0.00

Altman Z-Score 30.50

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -23.0%

Returns

Return on Assets -34.7%

Return on Equity -35.4%

Return on Invested Capital -40.3%

Return on Capital Employed -40.7%

Return on Tangible Assets -34.7%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 12.0%

EPS CAGR 5Y 10.1%

EPS CAGR 10Y N/A

FCF CAGR 3Y -5.3%

FCF CAGR 5Y -13.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 10

EPS Growth Next 3Y -10.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.40

EPS Growth Est (next Q) 21.2%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $21

Price Target Upside 65.7%

Cash Flow

Operating Cash Flow $-111.64M

Free Cash Flow $-112.42M

Adj. Free Cash Flow $-138.32M

FCF Per Share -$1.04

OCF Per Share -$1.03

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-584K

Operating Income $-156.14M

EBITDA $-143.28M

Net Income $-140.35M

EPS (Diluted) -$1.35

Revenue / Employee N/A

Profit / Employee $-1.26M

Employees 111